Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia

Cancer Science

Volumn 105, Issue 8, 2014, Pages 933-942

  Han, Yixiang ^a   Ye, Aifang ^a   Bi, Laixi ^a   Wu, Jianbo ^a   Yu, Kang ^a   Zhang, Shenghui ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Interleukin 17; Prognostic factors; Th1 cells; Th17 cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; JANUS KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE MARROW DERIVED MONONUCLEAR CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ACUTE MYELOID LEUKEMIA; INTERLEUKIN-17; PROGNOSTIC FACTORS; TH1 CELLS; TH17 CELLS;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 84906568277     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12459     Document Type: Article

References (40)

1. Le Dieu R, Taussig DC, Ramsay AG et al. Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood 2009; 114: 3909-16.
2. Ustun C, Miller JS, Munn DH, Weisdorf DJ, Blazar BR. Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? Blood 2011; 118: 5084-95.
3. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517.
4. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-67.
5. Huber M, Heink S, Pagenstecher A et al. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 2013; 123: 247-60.
6. Couturier M, Lamarthee B, Arbez J et al. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect. Leukemia 2013; 27: 1527-37.
7. Wilke CM, Kryczek I, Wei S et al. Th17 cells in cancer: help or hindrance? Carcinogenesis 2011; 32: 643-9.
8. Muranski P, Restifo NP. Does IL-17 promote tumor growth? Blood 2009; 114: 231-2.
9. Prabhala RH, Pelluru D, Fulciniti M et al. Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood 2010; 115: 5385-92.
10. Numasaki M, Fukushi J, Ono M et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101: 2620-7.
11. Tosolini M, Kirilovsky A, Mlecnik B et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71: 1263-71.
12. Amedei A, Niccolai E, Benagiano M et al. Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. Cancer Immunol Immunother 2013; 62: 1249-60.
13. Ye ZJ, Zhou Q, Gu YY et al. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol 2010; 185: 6348-54.
14. Jain P, Javdan M, Feger FK et al. Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance. Haematologica 2012; 97: 599-607.
15. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-52.
16. Lin H, Tong ZH, Xu QQ et al. Interplay of Th1 and Th17 Cells in Murine Models of Malignant Pleural Effusion. Am J Respir Crit Care Med 2014; 189: 697-706.
17. Kryczek I, Banerjee M, Cheng P et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009; 114: 1141-9.
18. van Beelen AJ, Zelinkova Z, Taanman-Kueter EW et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007; 27: 660-9.
19. Wu C, Wang S, Wang F et al. Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clin Exp Immunol 2009; 158: 199-204.
20. Ersvaer E, Liseth K, Skavland J, Gjertsen BT, Bruserud O. Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells. BMC Immunol 2010; 11: 38.
21. Tian T, Yu S, Wang M et al. Aberrant T helper 17 cells and related cytokines in bone marrow microenvironment of patients with acute myeloid leukemia. Clin Dev Immunol 2013; 2013: 915873.
22. Abousamra NK. Salah El-Din M, Helal R. Prognostic value of Th17 cells in acute leukemia. Med Oncol 2013; 30: 732.
23. Zhang S, Zhang Y, Zhuang Y et al. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS ONE 2012; 7: e46853.
24. Kesselring R, Thiel A, Pries R, Trenkle T, Wollenberg B. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. Br J Cancer 2010; 103: 1245-54.
25. Yao Z, Fanslow WC, Seldin MF et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3: 811-21.
26. Konopleva MY, Jordan CT. Leukemia stem cells and microenvironment: biology and therapeutic targeting. J Clin Oncol 2011; 29: 591-9.
27. Toh ML, Kawashima M, Hot A, Miossec P. Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rbeta2 inhibition. Ann Rheum Dis 2010; 69: 1562-7.
28. Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648-51.
29. Shenghui Z, Yixiang H, Jianbo W et al. Elevated frequencies of CD4(+) CD25(+) CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer 2011; 129: 1373-81.
30. Mussai F, De Santo C, Abu-Dayyeh I et al. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood 2013; 122: 749-58.
31. Yang L, Anderson DE, Baecher-Allan C et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454: 350-2.
32. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9: 641-9.
33. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
34. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-9.
35. Huang H, Kim HJ, Chang EJ et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ 2009; 16: 1332-43.
36. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6: 836-48.
37. Sansone P, Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 2012; 30: 1005-14.
38. Subramaniam SV, Cooper RS, Adunyah SE. Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem Biophys Res Commun 1999; 262: 14-9.
39. Zhang JP, Yan J, Xu J et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 2009; 50: 980-9.
40. Sanchez-Correa B, Bergua JM, Campos C et al. Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine 2013; 61: 885-91.